# Eisai Company Ltd. – FDA 483, Dec 21, 2018

Source: https://www.keypedia.com/records/483/eisai-company-ltd/3bee4a56-0e26-4371-977d-a900343008f7

> FDA 483 for Eisai Company Ltd. on December 21, 2018. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Eisai Company Ltd.
- Inspection Date: 2018-12-21
- Product Type: drugs
- Office Name: Office of Biological Products Operations - Division I
- Summary: Eisai Company Ltd. in Kakamigahara, Gifu, Japan, was inspected by the FDA from December 17-21, 2018, revealing significant deficiencies across multiple areas. The inspection found issues with production phase time limits, cleaning validation, equipment maintenance, record availability, laboratory controls, and employee training. These observations indicate a lack of adherence to good manufacturing practices that could impact drug product quality and integrity.

## Related Documents

- [483 - 2026-06-05](https://www.keypedia.com/records/483/eisai-company-ltd/5da76e40-5567-4aea-8d42-298b412ff04d) — date: June 5, 2026
- [483 - 2023-10-27](https://www.keypedia.com/records/483/eisai-company-ltd/7fd8e7d9-096a-4649-a299-3e5a14dd1033) — date: October 27, 2023
- [483 - 2022-11-01](https://www.keypedia.com/records/483/eisai-company-ltd/c8868908-8632-455c-9d1b-f9098bd68460) — date: November 1, 2022
- [483 - 2019-06-28](https://www.keypedia.com/records/483/eisai-company-ltd/74314d7e-eb90-4dca-9b43-ce25b021db49) — date: June 28, 2019

## Related Officers

- [Investigator](https://www.keypedia.com/people/saied-a-asbagh/215bfa90-995f-4310-baf3-cd9d37639b7b)

Company: https://www.keypedia.com/companies/eisai-company-ltd/3b8d9042-088d-4b84-9382-fcdcfd5ef360

Office: https://www.keypedia.com/offices/office-of-biological-products-operations-division-i/49c53dac-7724-4c8c-8708-4f5779ea69c1
